Lubabegron, Melengestrol Acetate, Monensin, Tylosin Phosphate Patent Expiration
About Veterinary Lubabegron, Melengestrol Acetate, Monensin, Tylosin Phosphate
Lubabegron, Melengestrol Acetate, Monensin, Tylosin Phosphate is used in a drug marketed by 1 company: Elanco Us Inc.
Other drugs containing Lubabegron, Melengestrol Acetate, Monensin, Tylosin Phosphate are: Mga and experior and rumensin and tylan .
Veterinary Lubabegron, Melengestrol Acetate, Monensin, Tylosin Phosphate Patents
Given below is the list of patents protecting Lubabegron, Melengestrol Acetate, Monensin, Tylosin Phosphate, along with the drug name that holds that patent and the company owning that drug.
| Drug Used In | Drug Patent Number | Drug Patent Expiry | Drug Owner |
|---|---|---|---|
 | |||
| MGA And Experior And Rumensin And Tylan | US6730792 | 20 Apr, 2025 | ELANCO US INC. |
Lubabegron, Melengestrol Acetate, Monensin, Tylosin Phosphate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List